Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease

Journal of Hepatology

Volumn 53, Issue 5, 2010, Pages 927-933

  Valenti, Luca ^a   Canavesi, Elena ^a   Galmozzi, Enrico ^a   Dongiovanni, Paola ^a   Rametta, Raffaela ^a   Maggioni, Paolo ^a   Maggioni, Marco ^b   Fracanzani, Anna Ludovica ^a   Fargion, Silvia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Genetics; Iron overload; Non alcoholic steatohepatisis; Thalassemia

Indexed keywords

ALPHA 1 ANTITRYPSIN; BETA GLOBIN; FERRITIN; FERROPORTIN; TRANSFERRIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BETA THALASSEMIA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; HYPERFERRITINEMIA; IRON METABOLISM; LIVER FIBROSIS; LIVER HEMOSIDEROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL;

ADULT; AGED; BETA-GLOBINS; FATTY LIVER; FEMALE; FERRITINS; HUMANS; IRON; IRON OVERLOAD; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MUTATION;

EID: 77957376214     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.05.023     Document Type: Article

References (37)

1. S. Bellentani, G. Saccoccio, F. Masutti, L.S. Croce, G. Brandi, and F. Sasso Prevalence of and risk factors for hepatic steatosis in Northern Italy Ann Intern Med 132 2000 112 117
2. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, and M. Lenzi Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 2001 1844 1850
3. L. Valenti, R. Rametta, P. Dongiovanni, M. Maggioni, A.L. Fracanzani, and M. Zappa Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis Diabetes 57 2008 1355 1362
4. A. Poonawala, S.P. Nair, and P.J. Thuluvath Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study Hepatology 32 2000 689 692
5. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, and P. Carucci Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140
6. N.M. Wilfred de Alwis, and C.P. Day Genetics of alcoholic liver disease and nonalcoholic fatty liver disease Semin Liver Dis 27 2007 44 54
7. L. Valenti, A.L. Fracanzani, P. Dongiovanni, G. Santorelli, A. Branchi, and E. Taioli Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease Gastroenterology 122 2002 274 280
8. L. Miele, G. Beale, G. Patman, V. Nobili, J. Leathart, and A. Grieco The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease Gastroenterology 135 2008 282 291 [e281]
9. R. Moirand, M.H. Mendler, A. Guillygomarc'h, P. Brissot, and Y. Deugnier Non-alcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload? J Hepatol 33 2000 1024 1026
10. L. Valenti, P. Dongiovanni, A.L. Fracanzani, G. Santorelli, E. Fatta, and C. Bertelli Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis Dig Liver Dis 35 2003 172 178
11. A.L. Fracanzani, L. Valenti, E. Bugianesi, M. Andreoletti, A. Colli, and E. Vanni The risk of severe liver disease in NAFLD with normal aminotransferase levels: a role for insulin resistance and diabetes Hepatology 48 2008 792 798
12. B. Turlin, M.H. Mendler, R. Moirand, D. Guyader, A. Guillygomarc'h, and Y. Deugnier Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients Am J Clin Pathol 116 2001 263 270
13. Y. Deugnier, and B. Turlin Pathology of hepatic iron overload World J Gastroenterol 13 2007 4755 4760
14. R.G. Ruddell, D. Hoang-Le, J.M. Barwood, P.S. Rutherford, T.J. Piva, and D.J. Watters Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor κB-regulated signaling in rat hepatic stellate cells Hepatology 49 2009 887 900
15. P. Dongiovanni, L. Valenti, A. Ludovica Fracanzani, S. Gatti, G. Cairo, and S. Fargion Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver Am J Pathol 172 2008 738 747
16. L. Valenti, A.L. Fracanzani, P. Dongiovanni, E. Bugianesi, G. Marchesini, and P. Manzini Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study Am J Gastroenterol 102 2007 1251 1258
17. P.C. Adams, D.M. Reboussin, J.C. Barton, C.E. McLaren, J.H. Eckfeldt, and G.D. McLaren Hemochromatosis and iron-overload screening in a racially diverse population N Engl J Med 352 2005 1769 1778
18. L. Valenti, A. Fracanzani, E. Bugianesi, P. Dongiovanni, E. Galmozzi, and E. Vanni HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease Gastroenterology 138 2010 905 912
19. L. Valenti, P. Dongiovanni, A. Piperno, A.L. Fracanzani, M. Maggioni, and R. Rametta Alpha1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage Hepatology 44 2006 857 864
20. M. Sartori, S. Andorno, M. Pagliarulo, C. Rigamonti, C. Balzola, and P. Pergolini Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis c Gut 56 2006 693 698
21. A. Piperno, R. Mariani, C. Arosio, A. Vergani, S. Bosio, and S. Fargion Haemochromatosis in patients with beta-thalassaemia trait Br J Haematol 111 2000 908 914
22. A. Altes, V. Bach, A. Ruiz, A. Esteve, A.F. Remacha, and M.P. Sarda Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes? Ann Hematol 88 2009 341 345
23. D.W. Swinkels, D. Girelli, C. Laarakkers, J. Kroot, N. Campostrini, and E.H. Kemna Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry PLoS ONE 3 2008 e2706
24. G. Bedogni, S. Bellentani, L. Miglioli, F. Masutti, M. Passalacqua, and A. Castiglione The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population BMC Gastroenterol 6 2006 33
25. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
26. P.G. Scheuer, R. Williams, and A.R. Muir Hepatic pathology in relatives of patients with hemochromatosis J Pathol Bacteriol 84 1962 53 64
27. G. Chalevelakis, K. Tsiroyannis, J. Hatziioannou, and G. Arapakis Screening for thalassaemia and/or iron deficiency: evaluation of some discrimination functions Scand J Clin Lab Invest 44 1984 1 6
28. J.E. Nelson, R. Bhattacharya, K.D. Lindor, N. Chalasani, S. Raaka, and E.J. Heathcote HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis Hepatology 46 2007 723 729
29. Nelson JE, Wilson L, Brunt EM, Yeh M, Kleiner DE, Unalp-Arida A, et al. Hepatic iron deposition in reticuloendothelial cells but not hepatocytes is associated with more severe NASH: results from the NASH clinical research network. 2009 International BioIron society meeting; 2009. p. 185.
30. L. Valenti, P. Dongiovanni, A.L. Fracanzani, and S. Fargion HFE mutations in nonalcoholic fatty liver disease Hepatology 47 2008 1794 1795 [author reply 1795-1796]
31. A. Giambona, C. Passarello, M. Vinciguerra, R. Li Muli, P. Teresi, and M. Anza Significance of borderline hemoglobin A2 values in an Italian population with a high prevalence of beta-thalassemia Haematologica 93 2008 1380 1384
32. B.R. Di Iorio, F. Aucella, C. Stallone, and V. Bellizzi Thalassaemia minor: national survey of uraemic patients under substitutive treatment G Ital Nefrol 19 2002 286 293
33. E. Camberlein, G. Zanninelli, L. Detivaud, A.R. Lizzi, F. Sorrentino, and S. Vacquer Anemia in beta-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression Haematologica 93 2008 111 115
34. K. Jungermann, and T. Kietzmann Oxygen: modulator of metabolic zonation and disease of the liver Hepatology 31 2000 255 260
35. A.T. Taher, Z.K. Otrock, I. Uthman, and M.D. Cappellini Thalassemia and hypercoagulability Blood Rev 22 2008 283 292
36. N. Assy, I. Bekirov, Y. Mejritsky, L. Solomon, S. Szvalb, and O. Hussein Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases World J Gastroenterol 11 2005 5834 5839
37. T. Tanaka, C.N. Roy, W. Yao, A. Matteini, R.D. Semba, and D. Arking A genome-wide association analysis of serum iron concentrations Blood 115 2010 94 96